NCNA Research and Charts

NCNA - NuCana PLC ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-06-30)

Last 0.06	Change ⇓ -0.03 (0.00%)	Volume 114,315,378
	Open 0.07	High 0.07	Low 0.06

8EMA (Daily) 0.09	40EMA (Daily) 0.19	50EMA (Daily) 0.25	STO (Daily) 22.833	MACD Hist (Daily) 0.017
8EMA (Weekly) 0.142	40EMA (Weekly) 0.89	50EMA (Weekly) 1.02	STO (Weekly) 3.973	MACD Hist (Weekly) 0.006


Company Profile
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.